| GM Outcome of Interest | Non-GM Outcome of Interest | Relative Risk | 95% Confidence Interval | Statistical Significance (p < 0.050)a | ||
Present | Absent | Present | Absent | ||||
Analysis of all rats studied (GM-fed n = 10; non-GM-fed n = 10) | |||||||
No. of rats with gland dilatations | 6 | 4 | 4 | 6 | 1.50 | 0.60-3.74 | NS |
No. of rats with gland dilatations that are lined by cells exhibiting PAS or AB/PAS staining | 4 | 6 | 0 | 10 | Undefined (>4.40)b | Undefined (0.59 - 33.07)b | NS |
No. of rats with gland dilatations that are lined by elongated cells | 6 | 4 | 0 | 10 | Undefined (>6.60)b | Undefined (0.95 - 45.74)b | 0.011* |
Subset analysis of only rats with gland dilatations (GM-fed n = 6; non-GM-fed n = 4) | |||||||
No. of rats with gland dilatations that are lined by cells exhibiting PAS or AB/PAS staining | 4 | 2 | 0 | 4 | Undefined. (>3.33)b | Undefined (0.53 - 21.03)b | NS |
No. of rats with gland dilatations that are lined by elongated cells | 6 | 0 | 0 | 4 | Undefined. (>4.29)b | Undefined (0.72 - 25.39)b | 0.005** |